X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6547) 6547
Publication (754) 754
Book Review (160) 160
Book Chapter (99) 99
Conference Proceeding (12) 12
Book / eBook (11) 11
Presentation (2) 2
Data Set (1) 1
Dissertation (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4691) 4691
index medicus (3741) 3741
oncology (3074) 3074
female (2316) 2316
cancer (2300) 2300
male (1874) 1874
middle aged (1777) 1777
metastatic melanoma (1606) 1606
aged (1596) 1596
chemotherapy (1498) 1498
metastasis (1437) 1437
adult (1396) 1396
care and treatment (1201) 1201
animals (1197) 1197
immunotherapy (1072) 1072
treatment outcome (942) 942
medicine & public health (877) 877
research (861) 861
tumors (833) 833
melanoma (795) 795
immunology (793) 793
antineoplastic combined chemotherapy protocols - therapeutic use (783) 783
metastatic colorectal-cancer (730) 730
health aspects (704) 704
pharmacology & pharmacy (693) 693
metastatic breast-cancer (680) 680
surgery (650) 650
therapy (575) 575
aged, 80 and over (561) 561
analysis (561) 561
breast cancer (561) 561
survival (531) 531
neoplasm metastasis (525) 525
antineoplastic agents - therapeutic use (513) 513
mice (513) 513
drug therapy (498) 498
clinical trials (487) 487
prognosis (487) 487
article (461) 461
cancer therapies (447) 447
medicine, research & experimental (444) 444
antineoplastic combined chemotherapy protocols - adverse effects (431) 431
neoplasms - therapy (427) 427
patients (425) 425
neoplasms - drug therapy (422) 422
metastatic breast cancer (416) 416
breast neoplasms - drug therapy (414) 414
dendritic cells (400) 400
cancer research (396) 396
neoplasms - immunology (394) 394
retrospective studies (390) 390
phase-ii trial (375) 375
disease-free survival (360) 360
metastases (359) 359
metastatic (359) 359
hematology, oncology and palliative medicine (352) 352
t cells (347) 347
breast neoplasms - pathology (344) 344
hematology (342) 342
trial (340) 340
colorectal cancer (334) 334
medical research (330) 330
cell lung-cancer (327) 327
review (325) 325
antineoplastic agents - adverse effects (321) 321
carcinoma (318) 318
neoplasm staging (318) 318
bevacizumab (317) 317
diagnosis (317) 317
antineoplastic agents (316) 316
in-vivo (312) 312
cell biology (309) 309
development and progression (306) 306
cell line, tumor (302) 302
lymphocytes (296) 296
docetaxel (293) 293
expression (292) 292
toxicity (292) 292
breast-cancer (291) 291
survival analysis (290) 290
drug administration schedule (287) 287
antimitotic agents (286) 286
survival rate (284) 284
clinical trials as topic (283) 283
antigens (277) 277
risk factors (277) 277
pharmacology/toxicology (276) 276
fluorouracil (270) 270
medicine (270) 270
oncology, experimental (269) 269
paclitaxel (269) 269
biotechnology & applied microbiology (264) 264
antibodies, monoclonal - therapeutic use (260) 260
melanoma - pathology (256) 256
1st-line treatment (253) 253
combined modality therapy (252) 252
phase-ii (248) 248
apoptosis (244) 244
colony-stimulating factor (244) 244
fluorouracil - administration & dosage (242) 242
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6573) 6573
French (23) 23
German (21) 21
Japanese (17) 17
Korean (11) 11
Spanish (3) 3
Turkish (2) 2
Arabic (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infection and Chemotherapy, ISSN 1341-321X, 10/2019
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 248 - 256
Immune checkpoint inhibitors can cause severe immune-related adverse events, with immune-related diarrhea and colitis (irColitis) being among the most frequent... 
Checkpoint inhibition | Colitis | CMV | Melanoma | SOLID-ORGAN TRANSPLANTATION | MANAGEMENT | ULCERATIVE-COLITIS | UNTREATED MELANOMA | METASTATIC MELANOMA | INFLAMMATORY-BOWEL-DISEASE | ONCOLOGY | PHASE-3 TRIAL | DOUBLE-BLIND | INFECTION | IPILIMUMAB | Predictive Value of Tests | Skin Neoplasms - drug therapy | Colitis - virology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cytomegalovirus Infections - chemically induced | Cytomegalovirus Infections - immunology | Antibodies, Viral - blood | Opportunistic Infections - chemically induced | Young Adult | Time Factors | Colitis - chemically induced | Aged, 80 and over | Cytomegalovirus Infections - virology | Ganciclovir - therapeutic use | Adult | Female | Colitis - drug therapy | Opportunistic Infections - immunology | Colitis - immunology | Cytomegalovirus - pathogenicity | Skin Neoplasms - pathology | Cytomegalovirus - genetics | Opportunistic Infections - virology | Skin Neoplasms - immunology | Antiviral Agents - therapeutic use | Risk Factors | Hospitals, University | Treatment Outcome | Melanoma - secondary | Host-Pathogen Interactions | Cytomegalovirus - immunology | Antineoplastic Agents, Immunological - adverse effects | Virus Activation - drug effects | Cytomegalovirus Infections - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Opportunistic Infections - drug therapy | Adolescent | Aged | Immunocompromised Host | DNA, Viral - genetics | Germany | Cytomegalovirus - drug effects | Prevention | Care and treatment | Corticosteroids | Cytomegalovirus infections | Cancer
Journal Article
INTERNATIONAL JOURNAL OF CANCER, ISSN 0020-7136, 05/2013, Volume 132, Issue 9, pp. 2076 - 2086
EpsteinBarr virus (EBV) is a known tumor virus associated with an increasing array of malignancies; however, the association of the virus with certain... 
DNA METHYLATION | EpsteinBarr virus | chromatin | EMT | HISTONE ACETYLATION | epigenetics | EPITHELIAL-MESENCHYMAL TRANSITION | NUCLEAR-PROTEIN 2 | HODGKINS-DISEASE | ONCOLOGY | BURKITTS-LYMPHOMA | GASTRIC-CARCINOMA | BARR-VIRUS | GENE-EXPRESSION | METASTATIC NASOPHARYNGEAL CARCINOMA
Journal Article
AMERICAN JOURNAL OF ROENTGENOLOGY, ISSN 0361-803X, 12/2019, Volume 213, Issue 6, pp. 1358 - 1365
OBJECTIVE. The purpose of this study was to compare the sensitivity, specificity, and helpfulness to referring clinicians of labeled leukocyte scintigraphy... 
DIAGNOSTIC-VALUE | infection | inpatients | tagged leukocytes | METAANALYSIS | F-18-FDG PET/CT | FDG PET/CT | METASTATIC INFECTION | UNKNOWN ORIGIN | INFLAMMATION | PROCEDURE GUIDELINE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FEVER
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2015, Volume 21, Issue 11, pp. 2624 - 2634
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 06/2010, Volume 37, Issue 6, pp. 1189 - 1197
In the acute setting of endocarditis it is very important to assess both the vegetation itself, as well as potential life-threatening complications, in order... 
Metastatic infection | FDG-PET | TOMOGRAPHY | DIAGNOSIS | Acute endocarditis | RISK-FACTORS | MANAGEMENT | F-18-FDG PET/CT | COMPLICATIONS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Embolism | FEVER
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198158 - e0198158
Expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4), a negative regulator of T-cell function, is increased in chronic HIV-1 infection. It was hypothesized... 
TRIAL | METASTATIC MELANOMA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | IMMUNE ACTIVATION | ANTIRETROVIRAL THERAPY | CTLA-4 | INFECTION | T-CELL EXHAUSTION | UP-REGULATION | EXPRESSION | HIV Infections - virology | Humans | Middle Aged | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Ipilimumab - adverse effects | Viremia - drug therapy | CTLA-4 Antigen - immunology | Dose-Response Relationship, Drug | HIV Infections - immunology | HIV-1 - immunology | Maximum Tolerated Dose | Adult | Female | HIV Infections - drug therapy | Viremia - immunology | CTLA-4 Antigen - antagonists & inhibitors | Ipilimumab - administration & dosage | Viremia - metabolism | HIV Infections - metabolism | Ipilimumab - pharmacokinetics | Safety and security measures | Immune response | Ipilimumab | HIV patients | Dosage and administration | Research | Drug therapy | Pharmacokinetics | Health aspects | HIV infection | Corticoids | Toxicity | Viremia | CD8 antigen | Chronic infection | Clinical trials | Cytotoxicity | Infections | Lymphocytes T | Metastasis | Hepatitis | CTLA-4 protein | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Paralysis | Drug dosages | Antinuclear antibodies | Chronic illnesses | Immune system | Antigens | Corticosteroids | Research & development--R&D | Melanoma | Diarrhea | Pharmacology | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Viability | Viral infections | Index Medicus | RNA | Research & development | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | R&D | HIV | Human immunodeficiency virus
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 08/2010, Volume 51, Issue 8, pp. 1234 - 1240
The timely detection of metastatic infectious foci in gram-positive bacteremia is crucial, because these foci often require prolonged antibiotic treatment or... 
CRITERIA | UNKNOWN ORIGIN | PROSPECTIVE MULTICENTER | F-18-FDG PET/CT | metastatic infection | STAPHYLOCOCCUS-AUREUS BACTEREMIA | ENDOCARDITIS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Staphylococcus aureus | bacteremia | FEVER
Journal Article
The American Journal of the Medical Sciences, ISSN 0002-9629, 2014, Volume 349, Issue 1, pp. 24 - 28
Journal Article